Introduction
The carnitine-acylcarnitine carrier (CAC) shuttles acylcarnitine esters, in exchange for free carnitine, across the inner mitochondrial membrane (Pande 1975; Ramsay and Tubbs 1975) . This transport is an essential step in the process of long-chain fatty-acid oxidation (Stanley 1987 purification and reconstitution into liposomes (Indiver. Furthermore, fatty acids are an important source of enct 1990, 1991(7, 19Jib, 19 2, 19M, li-. 5). Ih ecaiergy for heart muscle and also for skeletal muscle, during exercise, whereas ketone bodies are excellent substrates rier is embedded in the inner mitochondrial membrane and has an apparent molecular mass of 32.5 kD in rat liver (Indiveri et al. 1990 ). It governs a one-to-one exchange, between long-chain acylcarnitine esters and nonesterified carnitine, across the inner mitochondrial membrane and also the unidirectional transport of car nitine across this membrane, although less efficiently (Pande and Parvin 1980; Indiveri et al. 1991a) . Incor porated into liposomes, the purified carrier protein has substrate specificity and inhibitor sensitivities similar to Am. J. Hum. Genet. 61:1239-1245, / W those in intact mitochondria (Indiveri et al. 1990 . CAC operates according to a ping-pong mech anism (Indiveri et al. 1994 ).
Very recently we described the cDNA and amino acid sequence of the rat CAC (Indiveri et al. 1997) . These studies have shown that CAC belongs to a protein family that, so far, has been found to comprise 10 biochemically well-characterized mitochondrial carriers and also sev eral other members of unknown function that are be ginning to emerge with the advance of genomic DNA sequencing (Walker and Runswick 1993; Palmieri 1994; Crabeel et ah 1996; Palmieri et al. 1996) . These proteins have evolved from a common ancestor, by two-tandem gene duplication, and have related structures and mech anisms (Walker and Runswick 1993; .
We report on the nucleotide sequence of the human CAC cDNA and the corresponding amino acid sequence, as well as the distribution of CAC mRNA in human tissues. For the first time, a mutation has been found in the CAC cDNA of a unique, now 9-year-old, CAC-deficient patient. CCA AAA CCC ATC AOC CCO CTC AAO AAC CTO CTO OCC OOC (IOC T IT (KÍC OOC OTO TOC CTO OTO IT C OTC 21-41 and 481-501, respectively, of the human CAC cDNA sequence (fig. 1) ; for fragment 2, 5;-CCTGGA-GAACGGATCAAGTG-3' (sense F2) and 5-CAATTA-AGGAACTTCATGGCAA-3' (antisense R2), at posi tions 450-469 and ,928-949, respectively; and, for fragment 3, 5/-GCAGTGATGATCCGAGCCTTC-3/ (sense F3) and 5'-ACAGGTAGTATCTGGTCTGGAA-3' (antisense R3), at positions 873-893 and 1224-1245, respectively. For each fragment, 35 cycles of PCR were performed (92°C for 60 s, 60°C for 60 s, and 72°C for 90 s). The cycles were preceded by an initial denatura tion step at 95°C for 3 min and were followed by a final extension at 72°C for 10 min. Ten microliters of each PCR reaction was analyzed on 1.0% agarose gels with 0,5 /xg ethidium bromide/ml in 1 x Tris borate-EDTA. The nucleotide sequences of the PCR products were an alyzed by direct sequencing using the Tacj Dye Deoxy Terminator Cycle Sequencing Kit (Applied Biosystems), according to the manufacturer's recommendations,
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Results
double-stranded human liver cDNA (Clontech). In this case we employed two nested forward adaptor primCloning and Sequencing of Human CAC cDNA ers and two reverse-specific primers (TTGTGTCTG-CAGTCGGACCTTGAC and CCAGAGGGTGACCGTlie recently reported rat cDNA of CAC (Indiveri et al. 1997 ) was used for cloning and sequencing of the ACGAACACCAGGC, corresponding to nucleotides human CAC homologue. Four overlapping sequences 257-278 and 121-146, respectively, of the rat cDNA were amplified, by PCR using human liver cDNA as a sequence), DNA-sequence analysis was performed ac~ template, with synthetic oligonucleotide primers based cording to established procedures (Indiveri et al. 1997 ), on the m t CDNA sequence and, to extend the sequence to the 5' end, with two nested forward primers comple-
Noi them Biol Analysis
nientary to adaptors that were added to the 5' extremities The sequence corresponding to nucleotides 421-967 °f the human liver cDNA. The obtained cDNA sequence of the human CAC cDNA was used as a probe in northwas 1,243 bp in length and had an open reading frame ern blots performed on mRNA derived from various human tissues (Clontech). Northern blot analysis was performed according to standard protocols, with high stringency. The filters were autoradiographed at -80°C. of 903 bp (fig, 1) . Assignment of position 63 as the first nucleotide of the initiation codon was deduced from comparison with the CAC cDNA of rat liver (Indiveri et al. 1997) , since no stop codon was found in the 5' For normalization of the hybridization signals a probe UTR. I he sequence, which extended into the 3' nonencoding part of human actin (Clontech) was employed.
coding region, did not contain the polyadenylation sig nal. The protein encoded by the human CAC cDNA contains 30 1 amino acids, and its calculated molecular weight is 32,9 Id).
Mutation Detection
Total RNA was extracted (Chomczynski and Sacelli 1987) from cultured skin fibroblasts and was stored as » an ethanol precipitato at -80"C. A 5-M g sample of RNA (>l LAC >"RNA Human was reverse transcribed to cDNA, in 1 h at 42C > C, with A hybridization probe consisting of nucleotides 421-967 of the human liver CAC" cDNA was employed in northern blot experiments. Figure 2 shows the pres ence of one band for CAC mRNA, -1.8 kb in length, 200 U of Superscript II reverse transcriptase (Life Tech nologies), by use of oligo(dT) and random hexamer primers. Five microliters of this first-strand cDNA was subjected to PCR amplification. By PCR, we generated in various human tissue types. The CAC mRNA was three overlapping fragments that covered the entire cod-highly expressed in heart, skeletal muscle, and liver ris ing region, using the following synthetic oligonucleotide sues. A much lower level of expression was found in primers (Perkin Elmer): for fragment 1, 5'-GCAGGT-brain, placental, pancreatic, and kidney tissues and es-CGAGAACTGACAGAC-3' (sense FI) and 5'~TTTCTC~ pecially in lung tissue. These differences in the level of CTGAAGAAGCCTGAA-3' (antisense Rl), at positions expression of the CAC transcript in the various tissues Am. ] . Hum. Genet. 61:12.V)-124.S, 1997 (5) " Data are the mean ± SD. // = no. of controls. h ND -not detectable, tested were not due to variations in the amounts of RNA 32.9 kD. The amino acid sequences of human and rat CAC are highly conserved: there is ~90% identity be tween these species ( fig. 1) (Indiveri et al. 1997) . Human CAC differs from its rat counterpart in 29 amino acids, 15 of which are nonconserved. The identity between the human and rat CAC is less than that found for some other mitochondrial carriers. In fact, 97% identity was found between the human and rat 2-oxoglutarate car riers (lacobazzi et al. '1992; Dolce et al. 1994/; ) , and 95% identity was found between the human and rat citrate carriers (Kaplan et al. 1993; lacobazzi et al. 1997) and phosphate carriers (Ferreira et al, ' 1989; Dolce et al. 1994a) . Three repeated homologous domains, each 100 amino acids in length, can be distinguished in the loaded on the gel, since this was checked in a control human CAQ a characteristic previously recognized in experiment with an actin probe.
Biochemical Studies in the Index Patient
other mitochondrial transport proteins (Walker and Runswick 1993; . These domains are re lated to those found in the mitochondrial carrier-protein Biochemical measurements of intact cultured skin fifamily (Walker and Runswick 1993; ). broblasts showed a diminished oxidation rate of
The cDNA and deduced protein sequences are in labeled myristic and palmitic acid (66% and 27%, reGenBank (accession no. Y10319; http://www.ncbi.nhm spectively, of the control mean), as shown in table 1.
.nih.gov/Web/Genbank/index.htni). A Blast search for The oxidation rate of M C-labeled octanoate and butyrate was found to be normal (not shown). The activities of the various mitochondrial fatty acyl-CoA dehydrogen ases, the enoyl-CoA hydratases, the 3-hydroxyacyl-CoA dehydrogenases, and the 3-ketoacyl-CoA thiolases, as well as of carnitine palmitoyltransferases I and II, were all normal (not shown). As shown in table 1, the activity of CAC was not detectable.
Ala Thr Pro Asn Leu Stop --GCCACCCCCAACTTGTGAGG
Mutation Analysis
The CAC mRNA from cultured skin fibroblasts from the patient was reverse transcribed, and the cDNA was PCR amplified in three overlapping fragments. Sequenc ing of these fragments revealed an insertion of a cytosine in the cytosine-rich region of bp 955-959, as shown in figure 3 . This insertion changes the sequence of the CAC protein from amino acid 300 (asparagine to glutamine) to the carboxy terminus and expands the length of the protein by 2*1 amino acids, to 322 amino acids ( fig. 4A )< Hydrophilicity calculations were performed according to the Kyte-Doolittle method, for the peptide sequence of the wild-type and the patient's CAC. The values ob tained were used for Chou-Fasman predictions of the secondary structure of the protein. The Chou-Fasman two-dimensional plot ( fig. 4J3 ) showed a dramatic con formational change, at the C-terminal region, between the wild-type and the patient's CAC protein. The protein encoded by the human CAC gene is 301 amino acids long, and its calculated molecular weight is F ig u re 3
Sequences of CAC cDNA segments, with their accom panying amino acid codes, for a control (wild type) (/V) and the patient (i3). For the patient, a C insertion, resulting in a frameshift and an extension of the C terminus of the CAC] protein (underlined), is shown (arrow). /\, Primary C-terminnl amino acid sequence of wild-type (top) and patient's (bottom) CAC protein, ft, Predicted secondary structure, according to the Chou-Fasman algorithm, of wild-type (tof)) and patient's elongated (bottom) CAC, rous se seven
•rerent ex heart, skeletal muscle, and liver tissues, which is in fair pressed-sequence-tag (EST) clones (AA305590, R l 1780, agreement' with the clinical involvement of these tissues F08483, Z28872, AA378439, N77642, and N87428) in the patient. Much lower levels of expression were that originated from different human tissues. These EST found in brain, placental, kidney, and pancreatic tissues clones have sequences that are homologous with differ-and especially in lung tissue, ent parts of the CAC protein and are presumed to encode a carrier protein of unknown function.
Tissue Distribution o f CAC mRNA
CAC-Defident Patient
We have identified CAC deficiency in cultured skin fibroblasts from a child who survived a stormy neonatal The CAC defect was detected in the patient's fihroperiod due to her fatty-acid oxidation disorder, which blasts. It is likely that CAC deficiency occurs in all tisinvariably has been fatal in other patients (Stanley et al. sues , since no evidence for the existence of various tissue-1992; Pande et al. 1993; Brivet et aL 1994 Brivet et aL , 1996 ; Hispecific isoforms has been found. As shown in figure 2, ezen- Koning et al, 1995; Ogier de Baulney et al. 1995) , high levels of CAC mRNA transcripts were found in Direct sequencing of the entire cDNA of the patient re-vealed the presence of a homozygous insertion of a cy tosine nucleotide in the only cytosine-containing region, bp 955-959, resulting in a frameshift. We repeated se quencing of the cDNA of this patient and of three con trols, in three independent experiments, all of which re vealed the homozygous insertion in the patient's cDNA. This excludes the possibility of a mistake made by the Taq DNA polymerase in the PCR reaction. The region containing the insertion consists of five cytosine nucle otides, which makes confirmation of the insertion by restriction-enzyme analysis impossible. Unfortunately, no material from the other family members was available for further investigations, The CAG protein of the patient has an obviously changed C terminus: amino acids 300 and 301 are changed from asparagine and leucine, respectively, to glutamine and leucine, respectively, and the protein has been elongated by 21 amino acids. A Chou-Fasman pre diction shows a dramatically changed secondary struc ture. The C terminus is changed from a turn (in wildtype CAC) to a helix structure, in the patient. The molecular basis of the transport process mediated by the CAC is still unrevealed. A proper folding and orientation of the CAC protein in the mitochondrial membrane is crucial for adequate functioning. The novel extension in the patient contains a hydrophobic domain, which may be embedded in the mitochondrial inner membrane in stead of protruding into the intermembrane space. A diminished entrapping or binding capacity of the posi tive charge of the quaternary nitrogen of carnitine to the negative carboxylate of the CAC C-terminus can be hy pothesized for die patient. The alterations of the pa tient's CAC also may lead to instability of the protein. An impairment of the patient's CAC in substrate binding or translocation also can be considered. The functional consequences of the molecular defect apparently are re stricted, in view of the mild clinical phenotype of the patient. Surprisingly, no CAC activity was detectable in fibroblasts.
In the present study, we determined the sequence of the human cDNA of the mitochondrial CAC, showed differences in human tissue distribution, and defined the first molecular defect in a CAC-deficient patient. This study provides the techniques necessary to resolve the molecular basis of CAC deficiency. This may be of great importance for the reliable diagnosis of patients at risk and also may guide the way toward prenatal diagnosis of this severe type of inborn error in metabolism.
